These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


188 related items for PubMed ID: 1346737

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inhibition of the cutaneous response to histamine by H1-blocking agents. Quantitative evaluation of microvascular changes in the skin after histamine challenge and a comparison of the effects of a single intake of cetirizine and terfenadine.
    Van Neste D, Rihoux JP.
    Skin Pharmacol; 1988; 1(3):192-9. PubMed ID: 2908486
    [Abstract] [Full Text] [Related]

  • 8. In vitro effects of cetirizine and histamine on human neutrophil function.
    Van Epps DE, Kutvirt SG, Potter JW.
    Ann Allergy; 1987 Dec; 59(6 Pt 2):13-9. PubMed ID: 2892444
    [Abstract] [Full Text] [Related]

  • 9. Effect of cetirizine on cutaneous reactions to PAF, kallikrein and serum in patients with chronic urticaria.
    Juhlin L, Rihoux JP.
    Acta Derm Venereol; 1990 Dec; 70(2):151-3. PubMed ID: 1969202
    [Abstract] [Full Text] [Related]

  • 10. Clinical pharmacodynamics of antihistamines.
    Maddox DE, Reed CE.
    Ann Allergy; 1987 Dec; 59(6 Pt 2):43-8. PubMed ID: 2892449
    [Abstract] [Full Text] [Related]

  • 11. Cetirizine. A review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma, and chronic urticaria.
    Campoli-Richards DM, Buckley MM, Fitton A.
    Drugs; 1990 Nov; 40(5):762-81. PubMed ID: 1981354
    [Abstract] [Full Text] [Related]

  • 12. Cetirizine: a new H1 antagonist with antieosinophilic activity in chronic urticaria.
    Townley RG.
    J Am Acad Dermatol; 1991 Oct; 25(4):668-74. PubMed ID: 1686439
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The inhibiting effect of cetirizine 2 HC1 on eosinophil migration and its link to H1 blockade.
    Rihoux JP.
    Agents Actions Suppl; 1991 Oct; 33():409-15. PubMed ID: 1675836
    [Abstract] [Full Text] [Related]

  • 15. The effects of H1 antihistamines on the early allergic response.
    Baroody F, Proud D, Kagey-Sobotka A, Freidhoff L, Norman PS, Lichtenstein LM, Naclerio RM.
    Ann Allergy; 1989 Dec; 63(6 Pt 2):551-5. PubMed ID: 2574550
    [Abstract] [Full Text] [Related]

  • 16. Interference of cetirizine with the late eosinophil accumulation induced by either PAF or compound 48/80.
    Martins MA, Pasquale CP, e Silva PM, Pires AL, Ruffié C, Rihoux JP, Cordeiro RS, Vargaftig BB.
    Br J Pharmacol; 1992 Jan; 105(1):176-80. PubMed ID: 1350745
    [Abstract] [Full Text] [Related]

  • 17. Cetirizine: antiallergic therapy beyond traditional H1 antihistamines.
    Sheffer AL, Samuels LL.
    J Allergy Clin Immunol; 1990 Dec; 86(6 Pt 2):1040-6. PubMed ID: 1979800
    [Abstract] [Full Text] [Related]

  • 18. Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance.
    Takahashi H, Ishida-Yamamoto A, Iizuka H.
    Clin Exp Dermatol; 2004 Sep; 29(5):526-32. PubMed ID: 15347340
    [Abstract] [Full Text] [Related]

  • 19. Eosinophil infiltration: effects of H1 antihistamines.
    Fadel R, David B, Rassemont R, Herpin-Richard N, Borgnon A, Rihoux JP.
    J Am Acad Dermatol; 1991 Jun; 24(6 Pt 2):1094-6. PubMed ID: 1677013
    [Abstract] [Full Text] [Related]

  • 20. Additional properties of cetirizine, a new H1 antagonist.
    Naclerio RM.
    Allergy Proc; 1991 Jun; 12(3):187-91. PubMed ID: 1680095
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.